USANA Health Sciences USNA Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about USANA Health Sciences's other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is USANA Health Sciences's other accrued liabilities?
- USANA Health Sciences (USNA) reported other accrued liabilities of $87.01M in Q1 2026.
- How has USANA Health Sciences's other accrued liabilities changed year-over-year?
- USANA Health Sciences's other accrued liabilities decreased by 13.3% year-over-year, from $100.41M to $87.01M.
- What is the long-term trend for USANA Health Sciences's other accrued liabilities?
- Over 5 years (2020 to 2025), USANA Health Sciences's other accrued liabilities has grown at a -8.3% compound annual growth rate (CAGR), from $149.88M to $97.3M.
- What does other accrued liabilities mean?
- This captures miscellaneous short-term obligations that do not fit into standard categories like accounts payable or accrued compensation. It often includes items such as customer deposits, short-term tax provisions, or other minor contractual liabilities. It provides insight into the breadth of the company's short-term financial commitments.